03.10.15
Biotronik SE & Co. KG has launched the ProMRI SystemCheck, a new online tool for tracking the ProMRI status of implantable devices.
The online interface of ProMRI SystemCheck provides an easy reference for those looking to check if a certain pacemaker or implantable cardiac defibrillator (ICD) system is approved for magnetic resonance (MR) scanning. After selecting the country in an auto-complete menu, users input the names of pacemakers, ICDs, implantable cardiac monitors (ICMs) and leads. A single click then brings up information about whether these devices are MR conditional, the company claims in a news release. The site also includes a crucial overview of scanning conditions for particular device and lead combinations, as well as required checks for each device before scanning.
"Biotronik has always placed the utmost value on innovative and high quality products and their ease of use," said Wolf Ruhnke, vice president at Biotronik. "This is why we invest in online tools like the ProMRI System Check, which enables users to quickly and conveniently obtain important information about our ProMRI devices and leads."
Biotronik ProMRI technology enables patients with a pacemaker, implantable defibrillator, or cardiac resynchronization therapy defibrillator (CRT-D) or pacemaker (CRT-P) to undergo an magnetic resonance imaging (MRI) scan. ProMRI technology, according to the company, enables pacemaker patients, and now ICD patients, to undergo full-body scans. ICD patients now also may undergo ultra high field 3.0 T scans.
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.
The online interface of ProMRI SystemCheck provides an easy reference for those looking to check if a certain pacemaker or implantable cardiac defibrillator (ICD) system is approved for magnetic resonance (MR) scanning. After selecting the country in an auto-complete menu, users input the names of pacemakers, ICDs, implantable cardiac monitors (ICMs) and leads. A single click then brings up information about whether these devices are MR conditional, the company claims in a news release. The site also includes a crucial overview of scanning conditions for particular device and lead combinations, as well as required checks for each device before scanning.
"Biotronik has always placed the utmost value on innovative and high quality products and their ease of use," said Wolf Ruhnke, vice president at Biotronik. "This is why we invest in online tools like the ProMRI System Check, which enables users to quickly and conveniently obtain important information about our ProMRI devices and leads."
Biotronik ProMRI technology enables patients with a pacemaker, implantable defibrillator, or cardiac resynchronization therapy defibrillator (CRT-D) or pacemaker (CRT-P) to undergo an magnetic resonance imaging (MRI) scan. ProMRI technology, according to the company, enables pacemaker patients, and now ICD patients, to undergo full-body scans. ICD patients now also may undergo ultra high field 3.0 T scans.
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.